Orlistat also causes cramping and severe diarrhea in many obese patients because water molecules also fail to be taken up by the gut
During this time, adults taking a weight loss drug in clinical trials lost an average of about 10 percent of their starting body weight
These older medications produce less dramatic weight loss compared to semaglutide and tirzepatide, which supports the theory that the rate and magnitude of weight loss, rather than the GLP-1 receptor activation itself, drives most of the hair shedding
Mietlicki-Baase EG, Reiner DJ, Cone JJ, Olivos DR, McGrath LE, Zimmer DJ et al (2015)
Long-term studies are needed to validate the potential cardioprotective effects of low dose GLP-1 in generally healthy individuals What the evidence suggests: Animal studies show that low-dose GLP-1s may target hallmarks of brain aging and improve cognitive function in models of Parkinsons and Alzheimers
Additionally established injectable delivery infrastructure in clinics and hospitals guarantees sustained dominance
